乳腺癌内分泌治疗的最新进展 - Suppr

Suppr

超能文献

Recent advances in endocrine therapy of breast cancer.

作者信息

Howell A, Dowsett M

机构信息

CRC Department of Medical Oncology, University of Manchester, Christie Hospital, NHS Trust.

出版信息

BMJ. 1997 Oct 4;315(7112):863-6. doi: 10.1136/bmj.315.7112.863.

DOI:10.1136/bmj.315.7112.863

PMID:9353509

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2127570/

Abstract

摘要

相似文献

Recent advances in endocrine therapy of breast cancer.

BMJ. 1997 Oct 4;315(7112):863-6. doi: 10.1136/bmj.315.7112.863.

New stars in the sky of treatment for early breast cancer.

N Engl J Med. 2004 Mar 11;350(11):1140-2. doi: 10.1056/NEJMe048037.

[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].

Bull Cancer. 2004 Dec;91(12):917-27.

[Tamoxifen and breast cancer: is everything known already?].

Tumori. 1998 Nov-Dec;84(6):A1-5.

Third generation aromatase inhibitors in metastatic breast cancer patients failing tamoxifen. Randomized comparisons with megestrol acetate: a critical review.

Eur J Gynaecol Oncol. 2000;21(6):555-9.

Selecting adjuvant endocrine therapy for breast cancer.

Oncology (Williston Park). 2004 Dec;18(14):1733-44, discussion 1744-5, 1748, 1751-4.

Update on the current use of hormonals as therapy in advanced breast cancer.

Anticancer Drugs. 2003 Apr;14(4):265-73. doi: 10.1097/00001813-200304000-00003.

[Aromatase inhibitors in the adjuvant therapy of breast cancer].

Gynakol Geburtshilfliche Rundsch. 2005 Jun;45(3):132-6. doi: 10.1159/000085193.

Aromatase inhibitor development and hormone therapy: a perspective.

Semin Oncol. 2003 Aug;30(4 Suppl 14):12-22. doi: 10.1016/s0093-7754(03)00303-8.

Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?

J Natl Cancer Inst. 2006 Sep 20;98(18):1261-3. doi: 10.1093/jnci/djj387.

引用本文的文献

Preparation and Characterization of Chitosan and Inclusive Compound-Layered Gold Nanocarrier to Improve the Antiproliferation Effect of Tamoxifen Citrate in Colorectal Adenocarcinoma (Caco-2) and Breast Cancer (MCF-7) Cells.

Turk J Pharm Sci. 2022 Aug 31;19(4):391-399. doi: 10.4274/tjps.galenos.2021.48961.

A Case of Complete Response to Letrozol Treatment in a Postmenopausal Woman With Breast Cancer Who has Progressed After Multiple Lines of Chemotherapy.

World J Oncol. 2013 Feb;4(1):58-60. doi: 10.4021/wjon628w. Epub 2013 Mar 6.

Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells.

Oncotarget. 2017 Jul 31;8(41):70521-70537. doi: 10.18632/oncotarget.19737. eCollection 2017 Sep 19.

Trends in 1-year survival of people admitted to hospital in Ontario, 1994-2009.

CMAJ. 2013 Nov 5;185(16):E755-62. doi: 10.1503/cmaj.130875. Epub 2013 Sep 30.

Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.

Breast Cancer Res. 2012 Apr 4;14(2):R57. doi: 10.1186/bcr3161.

Adjuvant Endocrine Therapy in Premenopausal Patients.

Breast Care (Basel). 2008;3(5):311-316. doi: 10.1159/000156985. Epub 2008 Oct 17.

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.

Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003370. doi: 10.1002/14651858.CD003370.pub3.

Has tamoxifen had its day?

Breast Cancer Res. 2002;4(6):213-7. doi: 10.1186/bcr536. Epub 2002 Aug 27.

Tamoxifen resistance in breast cancer: elucidating mechanisms.

Drugs. 2001;61(12):1721-33. doi: 10.2165/00003495-200161120-00004.

Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.

Br J Cancer. 2001 Aug 3;85(3):317-24. doi: 10.1054/bjoc.2001.1925.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验